The role of fluorodeoxyglucose-positron emission tomography in the evaluation of seizure disorders.
Theodore
W H
WH
Clinical Epilepsy Section, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D003837:Deoxy Sugars; D003847:Deoxyglucose / Q000031:analogs & derivatives; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000523:psychology; D004827:Epilepsy / Q000000981:diagnostic imaging; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008279:Magnetic Resonance Imaging; D012640:Seizures / Q000000981:diagnostic imaging*; D013702:Temporal Lobe / Q000601:surgery; D014055:Tomography, Emission-Computed
D003837:Deoxy Sugars; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose